These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241 [TBL] [Abstract][Full Text] [Related]
43. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor. Huang P; Chen CH; Yang YH; Lin RT; Lin FC; Liu CK Cerebrovasc Dis; 2006; 22(5-6):423-8. PubMed ID: 16912476 [TBL] [Abstract][Full Text] [Related]
44. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Straub S; Junghans U; Jovanovic V; Wittsack HJ; Seitz RJ; Siebler M Stroke; 2004 Mar; 35(3):705-9. PubMed ID: 14752128 [TBL] [Abstract][Full Text] [Related]
45. Factors Associated with Survival in 97 Horses with Septic Pleuropneumonia. Arroyo MG; Slovis NM; Moore GE; Taylor SD J Vet Intern Med; 2017 May; 31(3):894-900. PubMed ID: 28271546 [TBL] [Abstract][Full Text] [Related]
46. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Eckert B; Koch C; Thomalla G; Kucinski T; Grzyska U; Roether J; Alfke K; Jansen O; Zeumer H Stroke; 2005 Jun; 36(6):1160-5. PubMed ID: 15890988 [TBL] [Abstract][Full Text] [Related]
47. Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome. Malec LM; Cooper J; Rudolph J; Michaels MG; Ragni MV J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):972-975. PubMed ID: 29135819 [TBL] [Abstract][Full Text] [Related]
48. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery. Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630 [TBL] [Abstract][Full Text] [Related]
49. Retinal arterial occlusion with LIF using rTPA. Hayreh SS Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599 [No Abstract] [Full Text] [Related]
50. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. Graber JJ; Nayak L; Deangelis LM J Neurooncol; 2012 May; 107(3):571-3. PubMed ID: 22179814 [TBL] [Abstract][Full Text] [Related]
51. Intrapleural alteplase in a patient with complicated pleural effusion. Walker CA; Shirk MB; Tschampel MM; Visconti JA Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166 [TBL] [Abstract][Full Text] [Related]
52. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals. Vaishnav AG; Pettigrew LC; Ryan S Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532 [TBL] [Abstract][Full Text] [Related]
53. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases. Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590 [TBL] [Abstract][Full Text] [Related]
54. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells. Yoeruek E; Spitzer MS; Tatar O; Biedermann T; Grisanti S; Lüke M; Bartz-Schmidt KU; Szurman P Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1392-7. PubMed ID: 18385055 [TBL] [Abstract][Full Text] [Related]
55. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis]. Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762 [TBL] [Abstract][Full Text] [Related]
56. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
57. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998 [TBL] [Abstract][Full Text] [Related]